#
Title
1

ACG Clinical Guidelines: Colorectal Cancer Screening 2021

2

Off-Label Use of Multitarget Stool DNA Testing in Primary Care

3

ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile

4

Controversies in Gastroparesis: Discussing the Sticky Points

5

Ursodeoxycholic Acid Response Is Associated With Reduced Mortality in Primary Biliary Cholangitis With Compensated Cirrhosi

6

ACG Clinical Guideline for the Diagnosis and Management of GERD

7

Comparative Safety of Endoscopic vs Radiological Gastrostomy Tube Placement

8

ACG Clinical Guidelines: Management of Benign Anorectal Disorders

9

Cholangiopathy After Severe COVID-19

10

Exploratory Comparative Effectiveness Trial of Green Kiwifruit, Psyllium, or Prunes in US Patients With Chronic Constipation

11

ACG Clinical Guideline: ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding

12

ACG Clinical Guideline: ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury

13

Gender Disparities in Food Security, Dietary Intake, and Nutritional Health in the United States

14

Evidence of Duodenal Epithelial Barrier Impairment and Increased Pyroptosis in Patients With Functional Dyspepsia

15

ACG Clinical Guideline: Management of Irritable Bowel Syndrome

16

Assessing for Eating Disorders: A Primer for Gastroenterologists

17

Environmental Impact of Endoscopy: “Scope” of the Problem

18

An Analysis of the GIquIC Nationwide Quality Registry Reveals Unnecessary Surveillance Endoscopies in Patients with Normal and Irregular Z-Lines

19

Impact of Famotidine Use on Clinical Outcomes of Hospitalized Patients with COVID-19

20

ACG Clinical Guideline: Clinical Use of Esophageal Physiologic Testing

21

ACG Clinical Guideline: Achalasia

22

COVID-19 and the Digestive System

23

ACG Clinical Guideline: Chronic Pancreatitis

24

ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth

25

ACG Clinical Guideline: Disorders of the Hepatic and Mesenteric Circulation

26

Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With IBS-D

27

Women With NAFLD Lose Protection Against Cardiovascular Disease

28

A Clinician's Guide to Celiac Disease HLA Genetics

29

A Practical Path to Transitioning From Pediatric to Adult IBD Care

30

Endoscopic Bariatric Therapy: A Guide to the Intragastric Balloon

31

ACG Clinical Guideline: Hereditary Hemochromatosis

32

Cannabinoid Use in Patients With Gastroparesis and Related Disorders

33

Fecal Microbiota Transplant for Patients With Primary Sclerosing Cholangitis

34

Detection of Gluten in Gluten-Free Labeled Restaurant Food Using Crowd-Sourced Data

35

Pros and Cons of CRC Screening for Adults Aged 45-49 Years

36

Using Ergonomics to Prevent Injuries for the Endoscopist

37

Diagnosis and Management of Primary Biliary Cholangitis

38

Influence of Dietary Restriction on Irritable Bowel Syndrome

39

A Randomized Controlled Trial of TELEmedicine for Patients with IBD (TELE-IBD)

40

ACG Clinical Guideline: Ulcerative Colitis in Adults

41

ACG Monograph on Management of Irritable Bowel Syndrome

42

Complications of Antireflux Surgery

43

Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium

44

ACG Clinical Guideline: Management of Crohn’s Disease in Adults

45

ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts

46

ACG Clinical Guideline: Alcoholic Liver Disease

47

When and How to Stop Surveillance Colonoscopy in Older Adults

48

Bezafibrate Plus Ursodeoxycholic Acid for Treatment of Pruritus in Primary Biliary Cholangitis

49

Low-Dose Linaclotide (72 μg) for Chronic Idiopathic Constipation

50

Bariatric Surgery Complications: What to Expect in Your GI Practice

51

Living on Liquids: A GI Dietitian’s Experience on EEN

52

ACG and the 80% by 2018 Colorectal Cancer Initiative

53

Bloating and Abdominal Distension: Old Misconceptions and Current Knowledge

54

ACG and CAG Clinical Guideline: Management of Dyspepsia

55

Early Aggressive Hydration Hastens Clinical Improvement in Mild Acute Pancreatitis

56

Do Primary Care Provider Strategies Improve Patient Participation in CRC Screening?

57

Aspiration Therapy for Weight Loss: Is the Squeeze Worth the Juice?

58

ACG Clinical Guideline: Preventive Care in IBD

59

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection

60

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries

61

Oropharyngeal pH Testing Does Not Predict Response to PPI Therapy in Patients with Laryngeal Symptoms

62

Biomarkers for Precision Medicine in IBD

63

Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D

64

Financial Incentives for Promoting Colorectal Cancer Screening

65

Prospective EUS-Based Approach to the Evaluation of Idiopathic Pancreatitis

66

Harnessing the Hashtag: A Standard Approach to GI Dialogue on Social Media

67

Clinical Features and Outcomes of CAM-Induced Acute Liver Failure and Injury

68

ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults

69

ACG Clinical Guideline: Management of Patients With Acute Lower Gastrointestinal Bleeding

70

ACG Clinical Guideline: Nutrition Therapy in the Adult Hospitalized Patient

71

Food: The Main Course to Wellness and Illness in Patients with IBS

72

ACG Clinical Guideline: Liver Disease and Pregnancy

73

ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus

74

Diagnosis of Minimal Hepatic Encephalopathy Using Stroop EncephalApp

75

Which CRE Prevention Strategy for ERCP Endoscopes Is Most Cost-Effective?

76

IBD Patients Are at Increased Risk of Invasive Pneumococcal Disease

77

The Clinical Impact of Immediate On-Site Cytopathology Evaluation During EUS-FNA of Pancreatic Masses

78

ACG Clinical Guideline on Small Bowel Bleeding

79

Should Chromoendoscopy Become the Standard of Care in IBD Surveillance?

80

ACG Clinical Guideline on Primary Sclerosing Cholangitis

81

Constipation and Fecal Incontinence During and After Pregnancy

82

Gluten Avoidance in Non-Celiac Patients

83

Medical Marijuana: High Time to Prescribe?

84

Listen to Dr. Philip Schoenfeld Explain New Quality Indicators for Colonoscopy and What They Mean for Your Practice in This Month’s AJG Podcast

85

Dr. Adil Bharucha Sheds Light on the Epidemiology, Pathophysiology, and Treatment of Fecal Incontinence in This Month’s AJG Podcast

86

What Level of Bowel Prep Quality Requires Early Repeat Colonoscopy: Systematic Review and Meta-Analysis of the Impact of Preparation Quality on ADR

87

ACG Monograph on the Management of IBS and Chronic Idiopathic Constipation-A Podcast with Eamonn M.M. Quigley, MD, FACG and Paul Moayyedi, BSc, MB ChB, PhD, MPH, FACG

88

ACG Clinical Guideline: The Diagnosis and Management of Focal Liver Lesions - A Podcast with Joseph Ahn, MD, FACG

89

ACG Clinical Guideline: Management of Benign Anorectal Disorders - A Podcast with Arnold Wald, MD, MACG

90

ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury - A Podcast with Naga P. Chalasani, MD, FACG, and Herbert L. Bonkovsky, MD, FACG

91

The Synergistic Effects of Alcohol and Tobacco Consumption on the Risk of Esophageal Squamous Cell Carcinoma: A Meta-Analysis - A Podcast with Joel H. Rubenstein, MD, MSc

92

Novel Role of the Serine Protease Inhibitor Elafin in Gluten-Related Disorders - A Podcast with Elena F. Verdu, MD, PhD

93

Avoiding Burnout: Finding Balance Between Work and Everything Else - A Podcast with Christina M. Surawicz, MD, MACG

94

Comparing Trends in Esophageal Adenocarcinoma Incidence and Lifestyle Factors Between the United States, Spain, and The Netherlands - A Podcast with Nicholas J. Shaheen, MD, MPH

95

The Impact of Physical Complaints, Social Environment, and Psychological Functioning on IBS Patients' Health Perceptions: Looking Beyond GI Symptom Severity - A Podcast with Jeffrey M. Lackner, PsyD

96

Differential Effects of FODMAPs (Fermentable Oligo-, Di-, Mono-Saccharides and Polyols) on Small and Large Intestinal Contents in Healthy Subjects Shown by MRI-A Podcast with Robin C. Spiller, MD, FRCP

97

Clinical and Endoscopic Characteristics do Not Reliably Differentiate PPI-Responsive Esophageal Eosinophilia and Eosinophilic Esophagitis in Patients Undergoing Upper Endoscopy: A Prospective Cohort Study-A Podcast with Evan S. Dellon, MD, MPH

98

Patient Assessments and Online Ratings of Quality Care: A "Wake-Up Call" for Providers-A Podcast with David A. Johnson, MD, FACG

99

Temporal Bacterial Community Dynamics Vary Among Ulcerative Colitis Patients After Fecal Microbiota Transplantation-A Podcast with Sieglinde Angelberger, MD, and David Berry, PhD

100

New Practice Guidelines on Acute Pancreatitis-A Podcast with Scott Tenner, MD, MPH, FACG

101

New Practice Guidelines on the Diagnosis and Management of Celiac Disease-A Podcast with Alberto Rubio-Tapia, MD

102

New Practice Guidelines on Achalasia-A Podcast with Michael F. Vaezi, MD, FACG, John E. Pandolfino, MD, and Marcelo F. Vela, MD

103

The Acid Pocket: A Target for Treatment in Reflux Disease?-A Podcast with Peter J. Kahrilas, MD, FACG

104

High Economic Burden of Caring for Patients With Suspected Extraesophageal Reflux-A Podcast with Michael F. Vaezi, MD, FACG, and David O. Francis, MD

105

New Practice Guidelines on the Diagnosis and Management of Celiac Disease-A Podcast with Joseph A. Murray, MD, FACG, and Ciarán P. Kelly, MD, FACG

106

New Practice Guidelines on Esophageal Eosinophilia and Eosinophilic Esophagitis (EoE)-A Podcast with David A. Katzka, MD, FACG

107

New Practice Guidelines on Clostridium difficile Infections-A Podcast with Christina M. Surawicz, MD, MACG

108

Expert Author Insight: New Practice Guidelines on GERD—A Podcast with Philip O. Katz, MD, FACG and Lauren B. Gerson, MD, MSc, FACG

109

The Role of Fecal Microbiota Transplant (FMT) in Treating C. difficile

110

Clinical Guideline: Management of Gastroparesis

111

Non-Celiac Wheat Sensitivity: Distinct Clinical Condition?

112

A 12-week, randomized controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation

113

The Prevalence of Irritable Bowel Syndrome Symptoms in Inflammatory Bowel Disease

114

New Meta-Analysis Shows No Protective Effect of 5-ASA Against CRC in IBD

115

Gut Microbes Supplement

116

Evidence Shows Higher Risk of C. diff Infection with PPIs – A Podcast with Yoon K. Loke, MD, MBBE

117

Endotherapy for Barrett's Esophagus

118

Food Choice as a Key Management Strategy for Functional Gastrointestinal Symptoms

119

Proton Pump Inhibitors versus Histamine 2 Receptor Antagonists for Stress Related Mucosal Bleeding Prophylaxis in Critically Ill Patients: A Meta-Analysis

120

Management of Patients with Ulcer Bleeding